Indoco Remedies Limited Total Assets

Latest as of March 2026: Rs25.93 Billion INR ≈ $280.45 Million USD

Indoco Remedies Limited total assets. Based on the latest financial reports, Indoco Remedies Limited (INDOCO) holds total assets worth Rs25.93 Billion INR (≈ $280.45 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see cash flow conversion of Indoco Remedies Limited for how efficiently the company converts equity into cash flow.

Total Assets of Indoco Remedies Limited (2004–2026)

Total assets of Indoco Remedies Limited from 2004 to 2026. This chart illustrates how Indoco Remedies Limited's total assets have evolved over time, based on quarterly financial data. See Indoco Remedies Limited (INDOCO) stock price for real-time trading data and today's change.

Indoco Remedies Limited - Asset Composition Analysis

Indoco Remedies Limited Total Assets Breakdown (March 2026)

Indoco Remedies Limited total assets breakdown as of March 2026. Indoco Remedies Limited's total assets of Rs25.93 Billion consist of 46.0% current assets and 54.0% non-current assets. Explore INDOCO working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.

Asset Category Amount (INR) % of Total Assets
Cash & Equivalents Rs0.00 1.0%
Accounts Receivable Rs4.94 Billion 19.0%
Inventory Rs4.05 Billion 15.6%
Property, Plant & Equipment Rs0.00 0.0%
Intangible Assets Rs1.79 Billion 6.9%
Goodwill Rs215.20 Million 0.8%

Asset Composition Trend (2004–2026)

This chart illustrates how Indoco Remedies Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Indoco Remedies Limited's current assets represent 46.0% of total assets in 2026, a decrease from 67.1% in 2004.
  • Cash Position: Cash and equivalents constituted 1.0% of total assets in 2026, down from 4.2% in 2004.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 0.0% in 2004.
  • Asset Diversification: The largest asset category is accounts receivable at 19.0% of total assets.

Indoco Remedies Limited Competitors by Total Assets

Key competitors of Indoco Remedies Limited based on total assets are shown below.

Company Country Total Assets
GALDERMA GROUP AG
NYSE:GALDY
USA $13.39 Billion
Takeda Pharmaceutical Company Limited
F:TKDA
Germany €15.41 Trillion
Galderma Group N
SW:GALD
Switzerland CHF12.88 Billion
Enzymatica publ AB
ST:ENZY
Sweden Skr149.24 Million
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
China CN¥13.98 Billion
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
China CN¥17.01 Billion
Kangmei Pharmaceutical Co Ltd
SHG:600518
China CN¥13.68 Billion
Walvax BioTech
SHE:300142
China CN¥10.50 Billion

Indoco Remedies Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.13 1.24 1.53
Quick Ratio 0.75 0.72 0.95
Cash Ratio 0.00 0.02 0.00
Working Capital Rs1.41 Billion Rs1.93 Billion Rs2.16 Billion

Indoco Remedies Limited - Advanced Valuation Insights

This section examines the relationship between Indoco Remedies Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.50
Latest Market Cap to Assets Ratio 0.01
Asset Growth Rate (YoY) 6.7%
Total Assets Rs25.93 Billion
Market Capitalization $207.64 Million USD

Valuation Analysis

Below Book Valuation: The market values Indoco Remedies Limited's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Indoco Remedies Limited's assets grew by 6.7% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Indoco Remedies Limited (2004–2026)

The table below shows the annual total assets of Indoco Remedies Limited from 2004 to 2026.

Year Total Assets Change
2026-03-31 Rs25.93 Billion
≈ $280.45 Million
+6.72%
2025-03-31 Rs24.30 Billion
≈ $262.79 Million
+13.30%
2024-03-31 Rs21.45 Billion
≈ $231.94 Million
+29.34%
2023-03-31 Rs16.58 Billion
≈ $179.33 Million
+11.58%
2022-03-31 Rs14.86 Billion
≈ $160.72 Million
+13.01%
2021-03-31 Rs13.15 Billion
≈ $142.22 Million
+3.42%
2020-03-31 Rs12.72 Billion
≈ $137.52 Million
+1.08%
2019-03-31 Rs12.58 Billion
≈ $136.05 Million
+1.76%
2018-03-31 Rs12.36 Billion
≈ $133.70 Million
+3.28%
2017-03-31 Rs11.97 Billion
≈ $129.45 Million
+24.20%
2016-03-31 Rs9.64 Billion
≈ $104.23 Million
+13.97%
2015-03-31 Rs8.46 Billion
≈ $91.45 Million
+15.93%
2014-03-31 Rs7.29 Billion
≈ $78.88 Million
+5.81%
2013-03-31 Rs6.89 Billion
≈ $74.55 Million
+5.02%
2012-03-31 Rs6.56 Billion
≈ $70.98 Million
+16.26%
2011-03-31 Rs5.65 Billion
≈ $61.06 Million
+17.85%
2010-03-31 Rs4.79 Billion
≈ $51.81 Million
+15.24%
2009-03-31 Rs4.16 Billion
≈ $44.96 Million
+11.00%
2008-03-31 Rs3.75 Billion
≈ $40.50 Million
+7.93%
2007-03-31 Rs3.47 Billion
≈ $37.53 Million
+11.69%
2006-03-31 Rs3.11 Billion
≈ $33.60 Million
+9.05%
2005-03-31 Rs2.85 Billion
≈ $30.81 Million
+89.27%
2004-03-31 Rs1.51 Billion
≈ $16.28 Million
--

About Indoco Remedies Limited

NSE:INDOCO India Drug Manufacturers - Specialty & Generic
Market Cap
$207.64 Million
Rs19.20 Billion INR
Market Cap Rank
#16205 Global
#823 in India
Share Price
Rs208.30
Change (1 day)
-0.57%
52-Week Range
Rs164.00 - Rs274.85
All Time High
Rs511.66
About

Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides bra… Read more